Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study.
about
Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under developmentInsulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery.An overview of clinical and commercial impact of drug delivery systemsUpdate on the treatment of type 2 diabetes mellitusBacterial proteins and peptides in cancer therapy: today and tomorrowNovel exenatide analogs with peptidic albumin binding domains: potent anti-diabetic agents with extended duration of actionLessons learned from the clinical development of oral peptides.Oral insulin reloaded: a structured approachOvercoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.Formulation strategies to improve oral peptide delivery.Challenges in the delivery of peptide drugs: an industry perspective.Efficacy and safety of oral insulin compared to subcutaneous insulin: a systematic review and meta-analysis.Pursuit of a perfect insulin.Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.Oral Insulin Delivery in a Physiologic Context: Review.Type 2 diabetes mellitus
P2860
Q26830274-C05D3E60-B1CF-4ADC-A338-CE7994EF2C52Q26865886-D378E814-2AC7-4A5A-90F6-2CF86ED71C2CQ27007143-4EB2649A-A224-431B-A592-CD795C3CD30AQ28073342-03F3AF2F-62FB-4A3D-A0F9-964CFCAF5DFAQ34075830-9601A1CC-4F6E-465F-AFAB-8991D78F010CQ35087618-65BB00FC-A6D2-4003-A03D-CFB3C12B9EB5Q35557405-807DBFD3-9F69-481F-92E8-97214AF375F4Q35682832-E9B82986-5088-4075-8B68-DAC8DCB9F4E9Q35684362-A0AF81CC-ABA6-4864-B43F-532FBF2E3BD0Q38226675-E2DDD676-A140-4F89-853B-07C55B64BB30Q38358860-C63A1262-D06A-4231-9B2B-727CB24E6F5AQ38536492-139B2310-17F7-42E4-B432-8D6E10AAFFB0Q38778988-19F69465-31D7-41C1-B8C6-0CCAD0816959Q38806457-90C028A3-D068-4E89-8AAC-52A3F63D7483Q39400642-7AF4428E-6650-4E10-9790-AA4543B19C5CQ58447602-A5753776-E513-49BE-93D9-044161F70CB7
P2860
Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@ast
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@en
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@nl
type
label
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@ast
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@en
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@nl
prefLabel
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@ast
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@en
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@nl
P2093
P2860
P1433
P1476
Glucose-reducing effect of the ...... ype 1 diabetes: a pilot study.
@en
P2093
Asher Corcos
Ehud Arbit
Miriam Kidron
P2860
P304
P356
10.1371/JOURNAL.PONE.0059524
P407
P577
2013-04-09T00:00:00Z